T-cell receptor transfer into human T cells with ecotropic retroviral vectors

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Gene Therapy

• Publication date

  2014-04-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/gt.2014.25PMID 24694535
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• T cell-based gene therapy of cancer.

  2013cited by this paper
• Scale-up and manufacturing of clinical-grade self-inactivating γ-retroviral vectors by transient transfection

  2011cited by this paper
• Transduction of Human Cells with Polymer-complexed Ecotropic Lentivirus for Enhanced Biosafety

  2011cited by this paper
• Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1.

  2011cited by this paper
• Engineered T cells for pancreatic cancer treatment.

  2011cited by this paper
• Determinants of intracellular RNA pharmacokinetics: Implications for RNA-based immunotherapeutics

  2011cited by this paper
• Phosphorothioate cap analogs increase stability and translational efficiency of RNA vaccines in immature dendritic cells and induce superior immune responses in vivo

  2010cited by this paper
• Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor.

  2010cited by this paper
• Transfer of mRNA encoding recombinant immunoreceptors reprograms CD4+ and CD8+ T cells for use in the adoptive immunotherapy of cancer

  2009cited by this paper
• Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen.

  2009cited by this paper
• The US and EU regulatory perspectives on the clinical use of hematopoietic stem/progenitor cells genetically modified ex vivo by retroviral vectors.

  2009cited by this paper
• Optimization of the PiggyBac Transposon System for the Sustained Genetic Modification of Human T Lymphocytes

  2009cited by this paper
• Targeting of the N‐terminal coiled coil oligomerization interface by a helix‐2 peptide inhibits unmutated and imatinib‐resistant BCR/ABL

  2008cited by this paper
• Simultaneous ex vivo quantification of antigen-specific CD4+ and CD8+ T cell responses using in vitro transcribed RNA

  2007cited by this paper
• Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes

  2006cited by this paper
• Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells.

  2006cited by this paper
• High-efficiency transfection of primary human and mouse T lymphocytes using RNA electroporation.

  2006cited by this paper
• Transduction of human embryonic stem cells by ecotropic retroviral vectors

  2006cited by this paper
• Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancer

  2002cited by this paper
• Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells.

  2001cited by this paper
• High-level transgene expression in primary human T lymphocytes and adult bone marrow CD34+ cells via electroporation-mediated gene delivery

  2000cited by this paper
• High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein.

  1998cited by this paper
• Amphotropic or gibbon ape leukemia virus retrovirus binding and transduction correlates with the level of receptor mRNA in human hematopoietic cell lines.

  1997cited by this paper
• Recombinant adeno-associated virus-mediated high-efficiency, transient expression of the murine cationic amino acid transporter (ecotropic retroviral receptor) permits stable transduction of human HeLa cells by ecotropic retroviral vectors

  1996cited by this paper
• Transient transfection of ecotropic retrovirus receptor permits stable gene transfer into non-rodent cells with murine retroviral vectors.

  1996cited by this paper
• The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction.

  1996cited by this paper
• Modulation of firefly luciferase stability and impact on studies of gene regulation.

  1991cited by this paper
• A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection.

  1989cited by this paper

• Molecular approaches to identify cancer T cell antigens and improve immunogenicity

  2023cites this paper
• MC38 colorectal tumor cell lines from two different sources display substantial differences in transcriptome, mutanome and neoantigen expression

  2023cites this paper
• A TCR-like CAR Promotes Sensitive Antigen Recognition and Controlled T-cell Expansion Upon mRNA Vaccination

  2022cites this paper
• A Trans-amplifying RNA Vaccine Strategy for Induction of Potent Protective Immunity.

  2020cites this paper
• An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors

  2020cites this paper
• A bicistronic vector backbone for rapid seamless cloning and chimerization of αβT-cell receptor sequences

  2020cites this paper
• Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3' UTRs Identified by Cellular Library Screening.

  2019cites this paper
• Multigene delivery in mammalian cells: Recent advances and applications.

  2018cites this paper
• Antigen-specific oncolytic MV-based tumor vaccines through presentation of selected tumor-associated antigens on infected cells or virus-like particles

  2017cites this paper
• Efficient Reprogramming of Human Fibroblasts and Blood-Derived Endothelial Progenitor Cells Using Nonmodified RNA for Reprogramming and Immune Evasion

  2015cites this paper
• Methods of Transfection with Messenger RNA Gene Vectors

  2015cites this paper
• Design and Production of mRNA-based Gene Vectors for Therapeutic Reprogramming of Cell Fate

  2015cites this paper